Pilot shows smartphone app and population management-facilitated Type-2 diabetes management can significantly improve blood glucose control
Glooko, the leading unified platform for diabetes management, today announced that Glooko was featured in a poster presentation on the effectiveness...
Glooko Announces Integration with the Roche Accu-Chek® Aviva Connect Blood Glucose Meters
Glooko Inc., the leading unified platform for diabetes management, today announced general availability of its integration with Roche ’s Accu-Chek Aviva...
Diabetes Thought Leaders Join the Glooko Medical Advisory Board
Glooko Inc., the leading unified platform for diabetes management, today announced the formation of its first Medical Advisory Board who will provide...
Medtronic expands access to diabetes device data through agreement with Glooko
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced an agreement with Glooko, the trusted leader in diabetes data unification...
Glooko to Highlight Integration of Insulin Pump and Continuous Glucose Monitor (CGM) Data into Its Diabetes Management Platform at ADA 2015 Conference
Glooko Inc. today announced it will demonstrate its integration with Insulin Pumps and Continuous Glucose Monitors (CGMs) at the American Diabetes Association’s...
Glooko partners with Dexcom® and Insulet® to add leading insulin pump and CGM devices to its platform
Glooko Inc. today announced partnerships with Dexcom, Inc., developer and marketer of a continuous glucose monitoring (CGM) system, and with Insulet Corporation,...
Glooko Appoints Serdar Akin as Vice President of Product Development and Michelle de Haaff as Vice President of Marketing and Customer Success
Glooko Inc., the leading unified platform for diabetes management, today announced the addition of two new executives to its management team.
Glooko, the Leading Remote Patient Monitoring Platform for Diabetes, Raises $16.5 Million in Series B Funding From Canaan Partners, Medtronic, Social + Capital and Samsung Glooko
Glooko Inc. today announced that it has raised $16.5 Million in Series B financing. The funds will be used to expand the company’s FDA-cleared, HIPAA-compliant...
